RT Journal Article
SR Electronic
T1 Cortical iron-related markers are elevated in mild Traumatic Brain Injury: An individual-level quantitative susceptibility mapping study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.10.29.24316391
DO 10.1101/2024.10.29.24316391
A1 Essex, Christi A.
A1 Overson, Devon K.
A1 Merenstein, Jenna L.
A1 Truong, Trong-Kha
A1 Madden, David J.
A1 Bedggood, Mayan J.
A1 Morgan, Catherine
A1 Murray, Helen
A1 Holdsworth, Samantha J.
A1 Stewart, Ashley W.
A1 Faull, Richard L. M.
A1 Hume, Patria
A1 Theadom, Alice
A1 Pedersen, Mangor
YR 2024
UL http://medrxiv.org/content/early/2024/10/30/2024.10.29.24316391.abstract
AB Quantitative susceptibility mapping (QSM) has been applied to map brain iron distribution after mild traumatic brain in-jury (mTBI), to understand properties of neural tissue which may be related to microstructural damage. However, mTBI is a heterogeneous injury associated with microstructural brain changes, and ‘traditional’ group-wise statistical approaches may lead to a loss of clinically relevant information, as subtle individual-level changes can be obscured by averages and confounded by within-group variability. More precise and individualised approaches are needed to characterise mTBI better and elucidate potential cellular mechanisms to improve intervention and rehabilitation. To address this issue, we build individualised profiles of regional positive (iron-related) magnetic susceptibility across 34 bilateral cortical regions of interest (ROIs) following mTBI. Healthy population templates were constructed for each cortical area using standardised z-scores derived from 25 age-matched male controls, serving as a reference against which z-scores of 35 males with acute (< 14 days) sports-related mTBI (sr-mTBI) were compared. Secondary analyses sensitive to cortical depth and curvature were also generated to approximate the location of iron accumulation in the cortical laminae and the effect of gyrification. Our primary analyses indicated that approximately one-third (11/35; 31%) of mTBI participants exhibited elevated positive sus-ceptibility indicative of abnormal iron profiles relative to the healthy control population, a finding that was mainly concentrated in ROIs within the temporal lobe. Injury severity was significantly higher (p < 0.01) for these mTBI participants than their iron-normal counterparts, suggesting a link between injury severity, symptom burden, and elevated cortical iron. Secondary analyses of cortical depth and curvature profiles revealed abnormal iron accumulation in 83% (29/35) of mTBI participants, enabling better localisation of mTBI-related changes in iron content to specific loci within each ROI and identifying effects that may be more subtle and lost in ROI-wise averaging. Our findings suggest that individualised approaches can further elucidate the clinical relevance of iron in mTBI. Differences in injury severity between iron-normal and iron-abnormal mTBI participants highlight not only why precise investigation is required to understand the link between objective changes in the brain and subjective symptomatology, but also identify iron as a candidate biomarker for tissue damage after mTBI.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis studywas funded by a grant from the Health Research Council of New Zealand (HRC), grant \#21/622Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Health and Disabilities Ethics Committee ethical approval for this work The Auckland University of Technology Ethics Committee gave institutional ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsDe-identified MRI data and code used for image processing and statistical analysis can be made available upon request to the corresponding author. Parent codes for cortical column generation can be made available upon request from co-authors (JLM, TKT) based at the Brain Imaging and Analysis Center at Duke University Medical Center.